Background: Chemotherapy in platinum-resistant ovarian cancer (PROC) aims for palliation
and prolonging of progression-free survival (PFS). This study compares Health-related …

Background Patients with platinum-sensitive recurrent ovarian cancer have variable
prognosis and survival. We extend previous work on prediction of progression-free survival …

OBJECTIVE: Endometrial stromal sarcoma (ESS) and leiomyosarcoma (LMS) are the two
most common uterine sarcomas, but both are rare tumors. The aim of the present study was …

Pregnancy outcome has been studied in terms of legal abortions, early spontaneous
abortions and total number of pregnancies (in an ad hoc study covering 6 counties) as well …

Undifferentiated uterine sarcomas (UUS) are a heterogenous group of high-grade
mesenchymal tumors. Although these tumors are highly aggressive, a subset of patients …

The objective of this study was to validate the diagnostic and clinical role of four protein
products of genes previously found to be differentially expressed in uterine low-grade …

The expression of Fey receptors (FcγR) and annexin II in 20 placentae (range 8–27 weeks'
gestation) and in 3 full‐term placentae was studied using monoclonal antibodies (mAbs) …

Annexin II (AII) is a member of a family of glycoproteins which bind negatively charged
phospholipids in a calcium‐dependent manner. Annexins are membrane‐associated …

Background Pelvic exenteration may be the only curative treatment for some patients with
primary advanced or recurrent vulvar cancer but is associated with high morbidity. This study …

CD59 is a 18–25kDa glycoprotein which, by inhibiting the formation of the membrane attack
complex, protects homologous cells from complement mediated damage. We have …